NAFDAC approves Pfizer COVID-19 vaccine

Screen grab of Pfizer COVID-19 vaccine

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of Pfizer COVID-19 in Nigeria.

NAFDAC’s approval is coming a few months after it gave a nod for the use of the Oxford-Astrazeneca jabs.

The Director-General of the agency, Mojisola Adeyeye announced this during a virtual meeting on Friday in Abuja, explaining that the vaccine is for emergency use.

Earlier in March, Nigeria had received 3.9 million doses of the Astranezeneca jabs and flagged off the vaccination exercise during an event organized by the National Primary Health Care Development Agency (NPHCDA) in Abuja.

DISCLAIMER

The OPINION / COLUMN is authored by independent contributors to the National Accord Newspaper. While contributors adhere to our editorial guidelines, they are not employed by the National Accord Newspaper. The perspectives and opinions expressed herein are solely those of the author and do not represent the views of the National Accord Newspaper or its staff.

Be the first to comment

Leave a Reply

Your email address will not be published.


*